湖北省慢性髓系白血病患者口服TKI 药物合并症调查结果和分析
吴要功， 王亚萍， 陈丽凤， 陈怡琳， 殷华， 熊颖媛… - 临床血液学 …, 2018 - lcxy.whuhzzs.com
… severe vascular events and other non-hematological complications in patients with chronic
myeloid leukemia … treatment of chronic myeloid leukaemia in the tyrosine kinase inhibitor era[J…
myeloid leukemia … treatment of chronic myeloid leukaemia in the tyrosine kinase inhibitor era[J…
[HTML][HTML] 博舒替尼治疗慢性粒细胞白血病现状
余艳玲， 余涛， 余甜， 万茜茜 - Advances in Clinical Medicine, 2023 - hanspub.org
… 摘要: 慢性粒细胞白血病(Chronic myeloid leukemia, CML)是一… 自酪氨酸激酶抑制剂(Tyrosine
kinase inhibitor, TKI)用于治疗… 对人血管内皮细胞(Human vascular endothelial cell, HUVEC)的…
kinase inhibitor, TKI)用于治疗… 对人血管内皮细胞(Human vascular endothelial cell, HUVEC)的…
[HTML][HTML] … Comments Off on The US FDA has issued full approval for Israeli drugmaker Teva's Synribo (omacetaxine mepesuccinate) 高三尖杉酯碱for chronic myeloid …
OFT BLOG - allfordrugs.com
… chronic or accelerated phase chronic myeloid leukemia (CML) with resistance and/or
intolerance to two or more tyrosine kinase inhibitors (… causes damage to heart and hematopoietic …
intolerance to two or more tyrosine kinase inhibitors (… causes damage to heart and hematopoietic …
高三尖杉酯碱巩固治疗慢性粒细胞白血病的有效性和安全性的荟萃分析
田怀平， 杨萍， 陶荣， 张金莲， 张健 - 中国药学(英文版), 2014 - jcps.bjmu.edu.cn
… therapy in chronic myeloid leukemia: a metaanalysis … or more tyrosine kinase inhibitors used
to treat accelerated or chronic … infections or impairment of vital organs (heart, liver or kidney) …
to treat accelerated or chronic … infections or impairment of vital organs (heart, liver or kidney) …
酪氨酸激酶抑制剂抗肿瘤治疗相关心脏毒性研究进展
袁铭， 刘彤 - 药学进展, 2018 - pps.cpu.edu.cn
… Incidences and outcomes of therapy-related chronic myeloid leukemia in the era of tyrosine
kinase inhibitors: … Cardiovascular safety of tyrosine kinase inhibitors: with a special focus on …
kinase inhibitors: … Cardiovascular safety of tyrosine kinase inhibitors: with a special focus on …
[HTML][HTML] 红细胞分布宽度在华氏巨球蛋白血症患者中的预后价值
何杰， 尹华， 王莉， 徐卫 - 南京医科大学学报(自然科学版), 2021 - jnmu.njmu.edu.cn
… cell distribution width in cardiovascular disease;current status … pa⁃ tients treated with tyrosine
kinase inhibitors[J].Antican⁃ … (chronic myeloid leukemia,CML),慢性淋巴细胞白血病(chronic …
kinase inhibitors[J].Antican⁃ … (chronic myeloid leukemia,CML),慢性淋巴细胞白血病(chronic …
[HTML][HTML] 中国服用酪氨酸激酶抑制剂的慢性髓性白血病慢性期患者共存疾病状况及其对患者报告结果的影响
于露， 江倩 - Chinese Journal of Hematology, 2018 - ncbi.nlm.nih.gov
… with chronic myeloid leukemia in chronic phase receiving tyrosine kinase-inhibitor therapy
… outcome of patients with chronic myeloid leukemia in chronic phase (CML-CP) receiving …
… outcome of patients with chronic myeloid leukemia in chronic phase (CML-CP) receiving …
[PDF][PDF] 酪氨酸激酶抑制剂致造血干细胞移植后肺动脉高压1 例
王崇慧， 梁赜隐， 易铁慈， 王智， 马为， 霍勇 - 肿瘤综合治疗电子杂志, 2023 - jmcm2018.com
… 术后间断使用二代酪氨酸激酶抑制剂(tyrosine kinase inhibitors,… 治疗慢性粒细胞白血病 (chronic
myeloid leukemia,CML)及费城… Dasatinib induces lung vascular toxicity and predisposes to …
myeloid leukemia,CML)及费城… Dasatinib induces lung vascular toxicity and predisposes to …
[HTML][HTML] Frankincense (乳香Rǔ Xiāng; Boswellia species): from the selection of traditional applications to the novel phytotherapy for the prevention and treatment of …
… It is the major cause of coronary heart disease and has been … induce apoptosis in six human
myeloid leukemia cell lines through a … Akt is a serine/threonine protein kinase which has an …
myeloid leukemia cell lines through a … Akt is a serine/threonine protein kinase which has an …
mTOR 信号通路在冠心病的研究进展
刘琪， 赵海静， 程龙， 刘昱圻 - 心脏杂志, 2020 - heartj.cn
… heart disease. This article mainly discusses the mechanism of mTOR in coronary heart
disease. … and glucocorticoid induced protein kinase,SGK)1 和蛋白激酶C(protein kinase C,PKC). …
disease. … and glucocorticoid induced protein kinase,SGK)1 和蛋白激酶C(protein kinase C,PKC). …